Angiopoietin-like Protein 3/8 Antibody for Mixed Hyperlipidemia: Phase 1 Trial
New Frontiers in Lipid Management: Promising Developments in Targeting ANGPTL3/8 As a health and science journalist, I’ve been following the evolving landscape of lipid management for years. Recent research, particularly concerning the targeting of angiopoietin-like proteins (ANGPTLs), offers exciting possibilities for treating dyslipidemia and reducing cardiovascular risk. Let’s dive into the promising developments and what … Read more